Cargando…

Blood-derived biomaterials for tissue graft biofabrication by solvent-based extrusion bioprinting

This article provides an overview of the different types of blood-derived biomaterials that can be used as solvent additives in the formulation of inks/bioinks for use in solvent extrusion printing/bioprinting. We discuss the properties of various blood sub-products obtained after blood fractionatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Amo, Cristina Del, Andia, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Whioce Publishing Pte. Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339460/
https://www.ncbi.nlm.nih.gov/pubmed/37457947
_version_ 1785071849486417920
author Amo, Cristina Del
Andia, Isabel
author_facet Amo, Cristina Del
Andia, Isabel
author_sort Amo, Cristina Del
collection PubMed
description This article provides an overview of the different types of blood-derived biomaterials that can be used as solvent additives in the formulation of inks/bioinks for use in solvent extrusion printing/bioprinting. We discuss the properties of various blood sub-products obtained after blood fractionation in terms of their use in tailoring ink/bioink to produce functional constructs designed to improve tissue repair. Blood-derived additives include platelets and/or their secretome, including signaling proteins and microvesicles, which can drive cell migration, inflammation, angiogenesis, and synthesis of extracellular matrix proteins. The contribution of plasma to ink/bioink functionalization relies not only on growth factors, such as hepatocyte growth factor and insulin growth factors, but also on adhesive proteins, such as fibrinogen/fibrin, vitronectin, and fibronectin. We review the current developments and progress in solvent-based extrusion printing/bioprinting with inks/bioinks functionalized with different blood-derived products, leading toward the development of more advanced patient-specific 3D constructs in multiple medical fields, including but not limited to oral tissues and cartilage, bone, skin, liver, and neural tissues. This information will assist researchers in identifying the most suitable blood-derived product for their ink/bioink formulation based on the intended regenerative functionality of the target tissue.
format Online
Article
Text
id pubmed-10339460
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Whioce Publishing Pte. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-103394602023-07-14 Blood-derived biomaterials for tissue graft biofabrication by solvent-based extrusion bioprinting Amo, Cristina Del Andia, Isabel Int J Bioprint Review Article This article provides an overview of the different types of blood-derived biomaterials that can be used as solvent additives in the formulation of inks/bioinks for use in solvent extrusion printing/bioprinting. We discuss the properties of various blood sub-products obtained after blood fractionation in terms of their use in tailoring ink/bioink to produce functional constructs designed to improve tissue repair. Blood-derived additives include platelets and/or their secretome, including signaling proteins and microvesicles, which can drive cell migration, inflammation, angiogenesis, and synthesis of extracellular matrix proteins. The contribution of plasma to ink/bioink functionalization relies not only on growth factors, such as hepatocyte growth factor and insulin growth factors, but also on adhesive proteins, such as fibrinogen/fibrin, vitronectin, and fibronectin. We review the current developments and progress in solvent-based extrusion printing/bioprinting with inks/bioinks functionalized with different blood-derived products, leading toward the development of more advanced patient-specific 3D constructs in multiple medical fields, including but not limited to oral tissues and cartilage, bone, skin, liver, and neural tissues. This information will assist researchers in identifying the most suitable blood-derived product for their ink/bioink formulation based on the intended regenerative functionality of the target tissue. Whioce Publishing Pte. Ltd. 2023-05-26 /pmc/articles/PMC10339460/ /pubmed/37457947 Text en Copyright:© 2023, Del Amo C, Andia I https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, permitting distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Amo, Cristina Del
Andia, Isabel
Blood-derived biomaterials for tissue graft biofabrication by solvent-based extrusion bioprinting
title Blood-derived biomaterials for tissue graft biofabrication by solvent-based extrusion bioprinting
title_full Blood-derived biomaterials for tissue graft biofabrication by solvent-based extrusion bioprinting
title_fullStr Blood-derived biomaterials for tissue graft biofabrication by solvent-based extrusion bioprinting
title_full_unstemmed Blood-derived biomaterials for tissue graft biofabrication by solvent-based extrusion bioprinting
title_short Blood-derived biomaterials for tissue graft biofabrication by solvent-based extrusion bioprinting
title_sort blood-derived biomaterials for tissue graft biofabrication by solvent-based extrusion bioprinting
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339460/
https://www.ncbi.nlm.nih.gov/pubmed/37457947
work_keys_str_mv AT amocristinadel bloodderivedbiomaterialsfortissuegraftbiofabricationbysolventbasedextrusionbioprinting
AT andiaisabel bloodderivedbiomaterialsfortissuegraftbiofabricationbysolventbasedextrusionbioprinting